Overlake piloting study for blood-based breast test

Liquid biopsy increases clarity of inconclusive mammogram results, may reduce invasive biopsies.

  • Wednesday, May 2, 2018 3:30pm
  • Life

Overlake Medical Center announced today it has enrolled 85 patients in a pilot study of a blood test that may determine which women with abnormal or inconclusive screening mammography results are at low risk for invasive breast cancer.

This technology, requiring a simple blood draw, will help physicians assess the likelihood of invasive cancer or precancerous lesions with difficult-to-interpret mammogram images, thus potentially reducing the need for invasive biopsies.

The EarlyGuard Breast Test is being developed by Toray Molecular Oncology Laboratory (TMOL) in Brisbane, California. The multi-center prospective clinical trial is enrolling 400 patients at seven medical institutions nationwide. Overlake is the only hospital in Washington State participating, and is the second highest enrolling site nationwide.

“Overlake is committed to helping advance medical technology in ways that benefit patients, especially in promoting less invasive testing methodologies,” said David Knoepfler, Overlake Chief Medical Officer in a press release.

Despite its effectiveness in reducing breast cancer deaths, screening mammography is associated with a high rate of false positive, or inconclusive results that lead to costly and invasive follow-up procedures, such as additional imaging tests or a tissue biopsy.

“It’s satisfying to be a part of advancing science,” said Overlake’s Steve Scallon, the study’s principal investigator in a press release. “It may be a helpful way for clinicians to better differentiate between high- and low-risk patients in the future.”

According to the American Cancer Society, for every woman screened, approximately 10-percent will be recalled for further testing, of which only three percent ultimately will be diagnosed with breast cancer. According to the Centers for Disease Control and Prevention, over 65 percent of women in the U.S. over the age of 40 are being screened every other year. For those patients who have been recommended to have an ultrasound guided biopsy, 75 percent of them will have a negative result. These false positives have the consequence of increased short-term anxiety for the women undergoing evaluation.

For patients like Reshil Offutt of Woodinville, WA whose screening mammography placed her in the American College of Radiology’s Breast Imaging Reporting and Data System (BI-RADS) Category 4 meaning suspicious for malignancy, the waiting period before the biopsy and afterwards while waiting for results was stressful.

“I scaled back on work after the biopsy and spent that week researching online and worrying,” said Offutt whose biopsy showed her lump to be benign, in a press release. “Anything that shortens the wait time is a good thing.”

Toray Chief Scientific Officer, Hideo Akiyama, PhD, says results of the pilot study are expected in early summer 2018. A pilot study is a necessary first step in exploring a new clinical intervention. A larger efficacy trial is expected to start in winter 2018.

More in Life

Ready or not, college is arriving

How parents can help their students embark on a college career.

After 70 years of serving, Grace Lutheran Church in Bellevue is permanently closed. The church donated $3.6 million to homeless services on the Eastside. Stephanie Quiroz/staff photo
Local church closes, donates assets to nonprofits

Grace Lutheran Church donates $3.6 million to homeless services on the Eastside.

Mindful goal setting | Health Column

What are the roots of you life goals?

Nityia Photography
Happy Fourth — Do we have freedom? What is freedom anyway?

A column about mindfulness and mental well being.

Celebrating the Fourth on the Eastside

Events around the Eastside.

Celebrating the Fourth on the Eastside

Americans all over the country including the Eastside region will gather on… Continue reading

Customer buys green leaves from Foothills Farms at the opening market day in Bellevue on May 16. Stephanie Quiroz/staff photo
It’s officially market season

Bellevue Farmers Market will run every Thursday through October.

Stephanie Quiroz/staff photo
                                Bellevue resident and blind cyclist Clark Roberts will be riding his tenth 206-mile Seattle to Portland bicycle ride in June.
The gift of sight loss

Bellevue’s Clark Roberts to ride his 10th Seattle-to-Portland bicycle ride

Ramit Malhotra and Tanvee Kale star in “Devi” at Allen Theatre at ACT. Photo courtesy of Siddhartha Saha Photography
Pratidhwani produces ‘Devi’ with Eastside actors

The show will feature actors from Bellevue, Redmond and Kirkland.

Stephanie Quiroz/staff photo 
                                Claire Cannon and daughter Riley, 2, pose for a photo while enjoying the sheep at the annual sheep shearing event at Kelsey Creek Farm on April 27.
Bellevue shears the fun at annual sheep shearing event

The day consisted of various sheep activities and pony rides.

Regional anesthesia improves outcomes for total knee replacement

The technique not only reduces pain, but allows patients to maintain muscle strength in the leg.